This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Regional De Lutte Contre Le Cancer Francois Baclesse, Institut De Cancerologie De L'ouest Rene Gauducheau, Université De Caen Basse Normandie. Active years: 2019.
Company Filing History:
1 out of 2 
1 out of 1 
1 out of 13 Years Active: 2019
Title: The Innovative Contributions of Serge Perato
Introduction
Serge Perato is a notable inventor based in Luc sur Mer, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. His work has the potential to impact the lives of many individuals affected by cancer.
Latest Patents
Serge Perato holds a patent for "Mcl-1 modulating compounds for cancer treatment." This invention relates to compounds of formula (I) and their therapeutic use in the treatment of cancer. His patent represents a crucial step forward in the ongoing battle against this devastating disease.
Career Highlights
Throughout his career, Serge has worked with esteemed organizations such as the Centre Régional de Lutte Contre Le Cancer François Baclesse and the Université de Caen Basse Normandie. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Serge has collaborated with talented individuals, including Jana Sopkova-de Oliveira Santos and Grégory Burzicki. These partnerships have fostered a creative environment that encourages innovation and the development of new ideas in cancer treatment.
Conclusion
In summary, Serge Perato's work in developing Mcl-1 modulating compounds showcases his dedication to advancing cancer treatment. His collaborations and career achievements highlight his significant role in the scientific community.